Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ELAN | US
0.36
1.61%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
24/04/2026
22.75
22.37
22.78
22.08
Elanco Animal Health Incorporated an animal health company innovates develops manufactures and markets products for pets and farm animals. It offers pet health disease prevention products such as parasiticide and vaccine products that protect pets from worms fleas and ticks under the Seresto Advantage Advantix and Advocate brands; pet health therapeutics for pain osteoarthritis ear infections cardiovascular and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines antibiotics parasiticides and other products for use in poultry and aquaculture production as well as nutritional health products including enzymes probiotics and prebiotics; and a range of vaccines antibiotics implants parasiticides and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers including beef and dairy farmers as well as pork poultry and aquaculture operations. The company was founded in 1954 and is headquartered in Greenfield Indiana.
View LessLargecap (10B - 200B USD)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
Price Below SMA10D
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Weak Operating Margin (< 10%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
37.2%1 month
40.7%3 months
40.5%6 months
37.3%-
12.22
1.07
0.96
0.41
-55.79
2.58
1.84
925.00M
11.25B
11.25B
-
9.71
-71.40
12.00
-18.79
2.43
4.03
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
2.65
Range1M
3.91
Range3M
5.95
Rel. volume
0.83
Price X volume
70.09M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc | JAZZ | Biotechnology | 196.52 | 12.14B | -1.72% | 19.50 | 153.92% |
| Ionis Pharmaceuticals Inc | IONS | Biotechnology | 73.26 | 11.55B | -1.12% | n/a | 749.72% |
| Madrigal Pharmaceuticals Inc | MDGL | Biotechnology | 512.39 | 11.13B | -1.22% | n/a | 13.77% |
| BioMarin Pharmaceutical Inc | BMRN | Biotechnology | 53.18 | 10.12B | -1.48% | 53.11 | 20.80% |
| Arrowhead Pharmaceuticals Inc | ARWR | Biotechnology | 73.91 | 9.19B | -0.66% | n/a | 137.39% |
| Axsome Therapeutics Inc | AXSM | Biotechnology | 185.96 | 8.93B | 1.77% | n/a | 186.48% |
| Bio-Techne Corporation | TECH | Biotechnology | 54.185 | 8.60B | 3.80% | 67.85 | 20.28% |
| Halozyme Therapeutics Inc | HALO | Biotechnology | 65.36 | 8.28B | -1.85% | 20.39 | 529.73% |
| Krystal Biotech Inc | KRYS | Biotechnology | 272.52 | 7.83B | 1.67% | 45.48 | 0.92% |
| Cytokinetics Incorporated | CYTK | Biotechnology | 65.32 | 7.69B | -0.24% | n/a | 727.94% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| FBIN | FBIN | Building Products & Equipment | 41.54 | 5.16B | 0.34% | 25.57 | 130.24% |
| Thor Industries Inc | THO | Recreational Vehicles | 79 | 4.18B | 0.24% | 23.44 | 27.88% |
| VeriFone Systems Inc | PAY | Building Products & Equipment | 27.25 | 3.39B | 0.96% | 102.46 | 2.10% |
| Polaris Industries Inc | PII | Recreational Vehicles | 60.04 | 3.35B | 1.06% | 14.48 | 170.51% |
| LCI Industries | LCII | Recreational Vehicles | 120.01 | 3.06B | -0.45% | 25.82 | 77.66% |
| Harley-Davidson Inc | HOG | Recreational Vehicles | 23.11 | 3.04B | -1.15% | 7.33 | 218.58% |
| Pitney Bowes Inc | PBI | Building Products & Equipment | 15.58 | 2.80B | 1.37% | n/a | -571.93% |
| HNI Corporation | HNI | Building Products & Equipment | 37.7 | 1.78B | 1.32% | 22.12 | 76.47% |
| Albany International Corp | AIN | Textile Manufacturing | 55.32 | 1.73B | -2.07% | 21.29 | 38.97% |
| Interface Inc | TILE | Textile Manufacturing | 28.1 | 1.64B | 0.57% | 17.81 | 106.26% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -55.79 | 24.85 | Cheaper |
| Ent. to Revenue | 2.58 | 361.91 | Cheaper |
| PE Ratio | - | 30.05 | - |
| Price to Book | 1.07 | 13.15 | Cheaper |
| Dividend Yield | - | 2.94 | - |
| Std. Deviation (3M) | 40.45 | 65.24 | Lower Risk |
| Debt to Equity | 0.96 | -1.88 | Expensive |
| Debt to Assets | 0.41 | 0.48 | Par |
| Market Cap | 11.25B | 3.71B | Market Leader |